Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mirelis

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|March 1, 1996
[Clinical relevance of gram-negative bacteria having inducible chromosomic beta-lactamase at an intensive care unit]F Navarro, C Alonso, J Ballús, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2005
Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, SpainA Rivera, M Rebollo, F Sánchez, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1987
Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditisR Pujadas, E Escriva, J Jane, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|November 24, 1999
[Incidence of extended spectrum beta lactamase in Escherichia coli in a university hospital from 1994-1996]M Sabaté, C Vergés, E Miró, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 1, 1992
[Evaluation of two commercial kits for detection of Helicobacter pylori specific antibodies in patients undergoing gastroscopy. A seroprevalence study in an asymptomatic population]F Navarro, P Coll, S Sáinz, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacinJ Vila, J Ruiz, F Sanchez, et al.
Microbiology and Immunology|May 15, 1998
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolatesJ Ruiz, P Goñi, F Marco, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2001
Quinolone resistance-determining regions of gyrA and parC in Pasteurella multocida strains with different levels of nalidixic acid resistanceM Cárdenas, J Barbé, M Llagostera, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2008
Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamasesL M Aragón, B Mirelis, E Miró, et al.
Journal of Clinical Microbiology|January 5, 2000
Escherichia coli serotype O15:K52:H1 as a uropathogenic cloneG Prats, F Navarro, B Mirelis, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Enfermedades Infecciosas Y Microbiologia Clinica|March 1, 1996
[Clinical relevance of gram-negative bacteria having inducible chromosomic beta-lactamase at an intensive care unit]F Navarro, C Alonso, J Ballús, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2005
Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, SpainA Rivera, M Rebollo, F Sánchez, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1987
Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditisR Pujadas, E Escriva, J Jane, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|November 24, 1999
[Incidence of extended spectrum beta lactamase in Escherichia coli in a university hospital from 1994-1996]M Sabaté, C Vergés, E Miró, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 1, 1992
[Evaluation of two commercial kits for detection of Helicobacter pylori specific antibodies in patients undergoing gastroscopy. A seroprevalence study in an asymptomatic population]F Navarro, P Coll, S Sáinz, et al.
Antimicrobial Agents and Chemotherapy|December 31, 1998
Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacinJ Vila, J Ruiz, F Sanchez, et al.
Microbiology and Immunology|May 15, 1998
Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolatesJ Ruiz, P Goñi, F Marco, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2001
Quinolone resistance-determining regions of gyrA and parC in Pasteurella multocida strains with different levels of nalidixic acid resistanceM Cárdenas, J Barbé, M Llagostera, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2008
Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamasesL M Aragón, B Mirelis, E Miró, et al.
Journal of Clinical Microbiology|January 5, 2000
Escherichia coli serotype O15:K52:H1 as a uropathogenic cloneG Prats, F Navarro, B Mirelis, et al.
Pageof 8